Min Yoon

Wonju Severance Christian Hospital

Papers

1

Total Citations

32

H-Index

1

About

Min Yoon is a leading anesthesiology researcher whose work centers on optimizing perioperative care and patient recovery outcomes. Her most significant contribution is a landmark 2022 randomized controlled trial comparing remimazolam—a novel intravenous benzodiazepine—to traditional inhalant agents for general anesthesia maintenance. This study, which has garnered 32 citations, was the first to rigorously evaluate postoperative quality of recovery in patients receiving remimazolam during total procedures. By demonstrating that this new agent may enhance patient-centered recovery metrics, Yoon’s research directly addresses a critical gap in anesthesiology: balancing effective intraoperative sedation with improved postoperative well-being. Her findings have immediate clinical implications, offering anesthesiologists evidence-based alternatives that could reduce recovery times and improve patient satisfaction. Yoon’s work exemplifies how targeted clinical trials can transform routine practice, and her focus on quality-of-life endpoints positions her at the forefront of patient-centered anesthesia research. For students and clinicians alike, her studies provide a compelling model for integrating novel pharmacologic agents into evidence-based perioperative protocols.

Research Focus

Key Achievements

1
H-Index
1
Papers
32
Total Citations
32
Avg Citations/Paper
🏆 Most Cited Paper
Quality of recovery in patients administered remimazolam versus those administered an inhalant agent for the maintenance of general anesthesia: a randomized control trial
32 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 3
🏛 Institutions: Wonju Severance Christian Hospital

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 13 days ago